This content is provided for informational, educational, and research purposes only
doi: 10.3389/fnut.2022.1082097
Seek immediate medical care if you experience: severe, persistent abdominal pain (particularly if radiating to the back), which could indicate pancreatitis
NICE guidance provides clear recommendations for GLP-1 use, which focus exclusively on glycaemic control in type 2 diabetes (NG28) and weight management in obesity (TA875 for semaglutide, TA664 for liraglutide)
Hucking K, Kostic Z, Pox C et al (2005) alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients
The drug must be treating that condition, not simply supporting general wellness